Monde Nissin [MONDE 8.30, up 1.8%; 62% avgVol] [link] put out a press release to tease a patchwork of FY23 and Q4 metrics. In the Meat Alternatives section, MONDE said that the non-meat protein segment “continues to navigate in a challenging environment”, and MONDE provided guidance that there would be a “single-digit decline for the fourth quarter” in this segment, but that the segment would “[be] at least EBITDA neutral”. MONDE then said that its annual impairment test for the meat alternative segment is “ongoing”, but that the company believes “the family’s financial support will largely cover any potential impairment at the parent level.”